EFFICACY OF MICRONIZED PROGESTERONE-CONTAINING TRANSDERMAL GEL IN THE TREATMENT OF FIBROCYSTIC MASTOPATHY: RESULTS OF A RUSSIAN STUDY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To evaluate the effect of progestogel as monotherapy on quality of life and magnitude of pain syndrome in fibrocystic mastopathy (FMP). Subjects and methods. The time course of changes in its symptoms was estimated using the pain visual analogue scale (VAS), the SF-6 health survey questionnaire, and ultrasonography in 798patients diagnosed with FMP. Results. The pain VAS scores were 5.7 (5.0; 7.0) at baseline and statistically significantly lower [(2.4 (1.0; 4.0)] and [1.0 (0.0; 2.0)] after 3 and 6 months, respectively (p<0.05). The rate of diffuse and nodular changes was decreased by 44.3 and 60.4%, respectively. That of cystic masses ≥ 10 mm or less was reduced by 61.8 and 4.3%, respectively. There were physical and emotional improvements. Conclusion. Three-month progestogel monotherapy for FMP contributes to a decline in the number and extent of cystic changes, significantly reduces the magnitude of pain syndrome, and improves the quality of physical and mental health.

Full Text

Restricted Access

About the authors

Elena N. Andreeva

Email: endogin@mail.ru
MD, Head of the medical-diagnostic department of endocrine gynecology, Endocrinology Research Center, Ministry of Health of Russia, Professor of the Department of Reproductive Medicine and Surgery, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia 115478, Russia, Moscow, Moskvorechie str. 1

Nadezhda I. Rozhkova

Email: 2013rozhkova@gmail.com
MD, Professor, Honored Scientist of Russia, winner of the USSR Council of Ministers Prize, director of the National Center of Oncology of Reproductive Organs, P.A. Herzen MNIOI, Ministry of Health of Russia; Professor, Department of Clinical mammology, radiation diagnosis and radiotherapy, Peoples Friendship University of Russia, President of the Russian Radiology Association, President of the Russian Mammologists Association, President of NGO Association “Mammalogy”, chairman of the section Women’s Radiology MOMP, a member of the Committee for European Radiology Association. 125284, Russia, Moscow, 2nd Botkinsky per. 3

References

  1. Meisner A.L., Fekrazad M.H., Royce M.E. Breast disease: benign and malignant. Med. Clin. North Am. 2008; 92(5): 1115-41.
  2. Ferrara A. Benign breast disease. Radiol. Technol. 2011; 82(5): 447M-62M.
  3. Amin A.L., Purdy A.C., Mattingly J.D., Kong A.L., Termuhlen P.M. Benign breast disease. Surg. Clin. North Am. 2013; 93(2): 299-308.
  4. Ader D.N., Shriver C.D. Cyclical mastalgia: prevalence and impact in an outpatient breast clinic sample. J. Am. Coll. Surg. 1997; 185(5): 466-70.
  5. Silva O.E., Zurrida S. Breast cancer. A practical guide. Elsevier Saunders; 2005.
  6. Ермилова В.Д. Морфологическая характеристика опухолей и опухолеподобных процессов молочной железы. В кн.: Хайленко В.А., Комов Д.В., Богатырев В.Н., ред. Диагностика рака молочной железы. М.: МИА; 2005: 150-9. [Ermilova V.D. Morphologic characteristics of tumor and tumor-like process in breast. In: Hailenko V.A., Komov D.V., Bogatyrev V.N., ed. Diagnostics of breast cancer. Moscow: MIA; 2005: 150-9. (in Russian)]
  7. Манухин И.Б., Высоцкий М.М., Харлова О.Г. Доброкачественные заболевания молочных желез. В кн.: Манухин И.Б., ред. Избранные лекции по гинекологии. М.: Династия; 2003: 71-80. [Manukhin I.B., Vysotsky M.M., Harlova O.G. Benign breast disease. In: Manukhin I.B., ed. Selected gynecological lectures. Moscow: Dynastia; 2003: 71-80. (in Russian)]
  8. Серов В.Н., Тагиева Т.Т. Доброкачественные заболевания молочных желез. В кн.: Серов В.Н., Прилепская В.Н., Овсянникова Т.В. Гинекологическая эндокринология. 3-е изд. М.: МЕДпресс-информ; 2008: 337-83. [Serov V.N., Tagieva T.T. Benign breast disease. In: Serov V.N., Prilepskaya V.N., Ovsyannikova T.V. Gynecological Endocrinology. 3rd ed. Moscow: MEDpress-inform; 2008: 337-83. (in Russian)]
  9. Хасанов Р.Ш., Гилязутдинов И.А. Мастопатия. Руководство для врачей. Казань: Новое знание; 2006. [Khasanov R.S., Giliazutdinov I.A. Mastopathy. Guideline for the doctors. Kazan: New knowledge; 2006. (in Russian)]
  10. Dyrstad S.W., Yan Y., Fowler A.M., Colditz G.A. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res. Treat. 2015; 149(3): 569-75.
  11. Plu-Bureau G., Lê M.G., Sitruk-Ware R., Thalabard J.C. Cyclical mastalgia and breast cancer risk: results of a French cohort study. Cancer Epidemiol. Biomarkers Prev. 2006; 15(6): 1229-31.
  12. Santen R.J. Benign breast disease in women. In: Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-2014, Feb 22.
  13. Андреева Е.Н., Овсянникова Т.В., Корженкова Г.П., Чистяков С.С., Пустотина О.А. и др. Доброкачественные заболевания молочных желез: клинические лекции по материалам школы «Современные аспекты патогенеза, диагностики и лечения заболеваний молочных желез». М.: Адаманть; 2006. [Andreeva E.N., Ovsyannikova T.V., Korzhenkova G.P., Chistyakov S.S., Pustotina O.A. et al. Benign breast diseases: Clinical lectures on the materials of the school “Modern aspects of pathogenesis, diagnosis and treatment of breast disease”. Moscow: Adamant; 2006. (in Russian)]
  14. Радзинский В.Е., Ордиянц И.М. Комплексный подход к диагностике и лечению гинекологических и маммологических заболеваний и нарушений. Маммология. 2005; 1: 12-7. [Radzinskiy V.E., Ordiyants I.M. Complex approach to the diagnostics and treatment of gynecological and mammological diseases ant disturbanses. Mammologiya. 2005; 1: 12-7. (in Russian)]
  15. Сидоренко Л.Н. Гормонотерапия предрака и рака молочной железы. СПб.: Медицина; 1996. [Sidorenko L.N. Hormonal treatment of precancer and cancer of breast. St. Petersburg: Medicina; 1996. (in Russian)]
  16. Fentiman I.S. The pathophysiology and therapy of benign breast disease. In: Fauser B.C. ed. Reproductive medicine: molecular, cellular and genetic funda mentals. Pathenon Publ.; 2003: 87-94.
  17. Winkler U.H., Schindler A.E., Brinkmann U.S., Ebert C., Oberhoff C. Cyclic progestin therapy for the management of mastopathy and mastodynia. Gynecol. Endocrinol. 2001; 15(Suppl. 6): 37-43.
  18. Аракелов С.Э., Масленникова М.Н., Павлова Е.А. и др. Дифференциальный подход к лечению женщин, страдающих болезнями молочных желез в сочетании с миомой матки. В кн.: Материалы II Междисциплинарного форума «Медицина молочной железы». М.: Медиабюро Статус Презенс; 2012. [Arakelov S.E., Maslennikova M.N., Pavlova E.A. et al. Differential approach to the treatment of women with breast diseases in combination with myoma uteri. In: Abstracts of the II Interdisciplinary forum “Medicine of breast”. Moscow: Status Praesens Mediabyuro; 2012. (in Russian)]
  19. Коган И.Ю., Мусина Е.В. Местное применение микронизированного прогестерона у больных репродуктивного возраста с мастопатией. Акушерство и гинекология. 2012; 2: 102-6. [Kogan I.Yu., Musina E.V. Topical use of micronized progesterone in reproductive-age patients with mastopathy. Akusherstvo i Gynecologiya/Obstetrics and Gynecology. 2012; 2: 102-6. (in Russian)]
  20. Brkic M., Vujovic S., Ivanisevic M.F., Ivovic M., Gajic M.T., Marina L. et al. The influence of progesterone gel therapy in the treatment of fibrocystic breast disease. Open J. Obstet. Gynecol. 2016; 6(5): 334-41.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies